View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
December 20, 2012

FDA approves Angiotech’s Bio-Seal Lung Biopsy Tract Plug system

The US Food and Drug Administration (FDA) has approved Angiotech Pharmaceuticals' proprietary biopsy device system, designed to prevent air leaks that can lead to a collapsed lung or pneumothorax, in patients undergoing lung biopsies.

By admin-demo

The US Food and Drug Administration (FDA) has approved Angiotech Pharmaceuticals’ proprietary biopsy device system, designed to prevent air leaks that can lead to a collapsed lung or pneumothorax, in patients undergoing lung biopsies.

"After healing of the puncture site, the plug gets absorbed into the body, according to the company."

The Bio-Seal Lung Biopsy Tract Plug system with proprietary hydrogel plug, when in contact with moist tissue, absorbs fluids and expands to fill the void created by the biopsy needle puncture.

After healing of the puncture site, the plug gets absorbed into the body, according to the company.

The approval was based on a multicentred, prospective, randomised clinical study, designed to evaluate the safety and efficacy of the biopsy device system.

Reduced rates of pneumothorax in patients undergoing lung biopsy procedures was the primary endpoint for the study.

Results demonstrated that the trial achieved its primary end point, with clinical success in 85% of patients treated with Bio-Seal, compared to 69% for the control patients (p=0.002), representing a 50% reduction in the risk of pneumothorax in the Bio-Seal patient group.

Angiotech Pharmaceuticals president and CEO Thomas Bailey said the device has also been shown to significantly reduce complication rates in patients receiving lung biopsy procedures.

"Bio-Seal represents a significant and proprietary addition to our broad portfolio of products for the diagnosis of cancer," Bailey added.

Bio-Seal system, which is expected to be sold under the brand name BioSentry, will be made available in the US in the first quarter of 2013.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU